A-Kinase Anchoring Protein Lbc Coordinates a p38 Activating Signaling Complex Controlling Compensatory Cardiac Hypertrophy

Molecular and Cellular Biology

Volumn 33, Issue 15, 2013, Pages 2903-2917

  López, Irene Pérez ^a   Cariolato, Luca ^a   Maric, Darko ^a   Gillet, Ludovic ^b   Abriel, Hugues ^b   Diviani, Dario ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN LBC; INITIATION FACTOR 4E BINDING PROTEIN 1; PHOSPHOTRANSFERASE; PROTEIN S6; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPENSATORY CARDIAC HYPERTROPHY; CONTROLLED STUDY; GENE ACTIVATION; HEART; HEART AFTERLOAD; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; STRESS; TRANSGENIC MOUSE;

A KINASE ANCHOR PROTEINS; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84880685427     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00031-13     Document Type: Article

References (38)

1. Hill JA, Olson EN. 2008. Cardiac plasticity. N. Engl. J. Med. 358:1370-1380.
2. Towbin JA, Bowles NE. 2002. The failing heart. Nature 415:227-233.
3. Pawson CT, Scott JD. 2010. Signal integration through blending, bolstering and bifurcating of intracellular information. Nat. Struct. Mol. Biol. 17:653-658.
4. Scott JD, Dessauer CW, Tasken K. 2013. Creating order from chaos: cellular regulation by kinase anchoring. Annu. Rev. Pharmacol. Toxicol. 53:187-210.
5. Diviani D. 2008. Modulation of cardiac function by A-kinase anchoring proteins. Curr. Opin. Pharmacol. 8:166-173.
6. Diviani D, Dodge-Kafka KL, Li J, KapiloffMS. 2011. A-kinase anchoring proteins: scaffolding proteins in the heart. Am. J. Physiol. Heart Circ. Physiol. 301:H1742-H1753.
7. Carnegie GK, Burmeister BT. 2011. A-kinase anchoring proteins that regulate cardiac remodeling. J. Cardiovasc. Pharmacol. 58:451-458.
8. Diviani D, Soderling J, Scott JD. 2001. AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation. J. Biol. Chem. 276:44247-44257.
9. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, Pedrazzini T, Diviani D. 2007. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 104:10140-10145.
10. Carnegie GK, Soughayer J, Smith FD, Pedroja BS, Zhang F, Diviani D, Bristow MR, Kunkel MT, Newton AC, Langeberg LK, Scott JD. 2008. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol. Cell 32:169-179.
11. Edwards HV, Scott JD, Baillie GS. 2012. The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of HSP20 on Ser(16). Biochem. J. 446:437-443
12. del Vescovo CD, Cotecchia S, Diviani D. 2013. AKAP-Lbc anchors IKKbeta to support interleukin-6-mediated cardiomyocyte hypertrophy. Mol. Cell Biol. 33:14-27.
13. Cariolato L, Cavin S, Diviani D. 2011. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in alpha1-adrenergic receptor-induced p38 activation. J. Biol. Chem. 286:7925-7937.
14. Streicher JM, Ren S, Herschman H, Wang Y. 2010. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 106:1434-1443.
15. Marber MS, Rose B, Wang Y. 2011. The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J. Mol. Cell. Cardiol. 51:485-490.
16. Palermo J, Gulick J, Colbert M, Fewell J, Robbins J. 1996. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ. Res. 78:504-509.
17. Wang Y, Huang S, Sah VP, Ross J, Jr, Brown JH, Han J, Chien KR. 1998. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:2161-2168.
18. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y. 2001. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 98:12283-12288.
19. Nishida K, Yamaguchi O, Hirotani S, Hikoso S, Higuchi Y, Watanabe T, Takeda T, Osuka S, Morita T, Kondoh G, Uno Y, Kashiwase K, Taniike M, Nakai A, Matsumura Y, Miyazaki J, Sudo T, Hongo K, Kusakari Y, Kurihara S, Chien KR, Takeda J, Hori M, Otsu K. 2004. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol. 24:10611-10620.
20. Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, Zorzato F, Krishnan J, Lerch R, Hall MN, Ruegg MA, Pedrazzini T, Brink M. 2011. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123: 1073-1082.
21. Zhang D, Contu R, Latronico MV, Zhang J, Rizzi R, Catalucci D, Miyamoto S, Huang K, Ceci M, Gu Y, Dalton ND, Peterson KL, Guan KL, Brown JH, Chen J, Sonenberg N, Condorelli G. 2010. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J. Clin. Invest. 120:2805-2816.
22. Frey N, Katus HA, Olson EN, Hill JA. 2004. Hypertrophy of the heart: a new therapeutic target? Circulation 109:1580-1589.
23. Pare GC, Bauman AL, McHenry M, Michel JJ, Dodge-Kafka KL, KapiloffMS. 2005. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J. Cell Sci. 118:5637-5646.
24. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, KapiloffMS, Scott JD. 2005. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437: 574-578.
25. Li J, Negro A, Lopez J, Bauman AL, Henson E, Dodge-Kafka K, KapiloffMS. 2010. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin. J. Mol. Cell. Cardiol. 48:387-394.
26. Zhang L, Malik S, Kelley GG, KapiloffMS, Smrcka AV. 2011. Phospholipase C epsilon scaffolds to mAKAP and integrates multiple hypertrophic stimuli in cardiac myocytes. J. Biol. Chem. 286:23012-23021.
27. Abrenica B, AlShaaban M, Czubryt MP. 2009. The A-kinase anchor protein AKAP121 is a negative regulator of cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 46:674-681.
28. Smith FD, Langeberg LK, Cellurale C, Pawson T, Morrison DK, Davis RJ, Scott JD. 2010. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat. Cell Biol. 12:1242-1249.
29. Takagi H, Hsu CP, Kajimoto K, Shao D, Yang Y, Maejima Y, Zhai P, Yehia G, Yamada C, Zablocki D, Sadoshima J. 2010. Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion. Circ. Res. 107:642-649.
30. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC. 1997. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J. Cell Biol. 139:115-127.
31. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, Meloche S, Nemer M. 2001. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev. 15:2702-2719.
32. Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD. 2003. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J. Clin. Invest. 111:1475-1486.
33. Zhang S, Weinheimer C, Courtois M, Kovacs A, Zhang CE, Cheng AM, Wang Y, Muslin AJ. 2003. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest. 111:833-841.
34. Martindale JJ, Wall JA, Martinez-Longoria DM, Aryal P, Rockman HA, Guo Y, Bolli R, Glembotski CC. 2005. Overexpression of mitogenactivated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo. J. Biol. Chem. 280:669-676.
35. Engel FB. 2005. Cardiomyocyte proliferation: a platform for mammalian cardiac repair. Cell Cycle 4:1360-1363.
36. Zeidan A, Hunter JC, Javadov S, Karmazyn M. 2011. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy. Mol. Cell. Biochem. 352:99-108.
37. Hernandez G, Lal H, Fidalgo M, Guerrero A, Zavilde J, Force T, Pombo CM. 2011. A novel cardioprotective p38-MAPK/mTOR pathway. Exp. Cell Res. 317:2938-2949.
38. Frey N, Olson EN. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:45-79.